One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Our pipeline reflects our strategy and is split between our later stage commercial pipeline and our NCE portfolio.


  • Building a profitable and cash generative business
  • Developing and commercialising low-risk late stage products for unmet medical need
  • Partnering all of our drug candidates; selective investment in our in-house products
  • Highly experienced executive and senior management team


See where Vernalis is now

View the pipeline, plus our staffing and research capabilities

Get an Overview

Clear direction for the competitive biotech sector

What therapeutic areas are we targeting, and what strategies do we rely on to achieve results?

Vision and strategy

Experienced, successful, engaged leadership

For a company this size, our directors and senior management stand out

Meet Our People

Where does Vernalis come from?

The history of the organisation, and the relationships we’ve developed

A little History

Interested in working with us?

Check out current vacancies and see the specialisations we are looking for

Careers at Vernalis

We take our responsibilities seriously

Good governance and good practice are inherent in all our operations

Corporate Social Responsibility

Latest News

Third Product in Vernalis’ Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept

Vernalis plc and Tris Pharma, Inc. today announce the achievement of proof-of-concept (POC) for CCP-08, the third programme to achieve this milestone in their US prescription cough cold collaboration ...



Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form